.gif)
CTT PHARMACEUTICAL HOLDINGS, INC.
51
There is no recent news coverage directly related to CTT PHARMACEUTICAL HOLDINGS, INC. The available recent news items pertain to other companies and sectors.
CTT PHARMACEUTICAL HOLDINGS, INC. is a publicly reporting company with limited publicly available information regarding its business operations, industry classification, and geographic focus. The latest SEC 10-Q filing dated September 17, 2026, provides a financial snapshot for the period ending June 30, 2026, indicating a net loss and a cash ratio below 1, suggesting liquidity constraints. The company is designated as a smaller reporting company and does not disclose detailed risk factors in its filings.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Not applicable due to insufficient public information on the company's business model, growth initiatives, or market position.
The company reported a significant net loss and a cash ratio below 1 as of June 30, 2026, indicating potential liquidity challenges. The absence of detailed disclosures and risk factors limits visibility into operational risks and financial stability.
Due to the lack of detailed public information on CTT PHARMACEUTICAL HOLDINGS, INC.'s business model, competitive positioning, or intellectual property, it is not possible to assess any sustainable competitive advantages or moat characteristics.
• Liquidity Risk: The company's cash ratio of 0.78 as of June 30, 2026, indicates that cash and cash equivalents cover less than the current liabilities, which may pose liquidity challenges.
• Financial Performance Risk: A net loss of $99,908 USD was reported for the latest period, reflecting ongoing unprofitability.
• Disclosure and Transparency Risk: As a smaller reporting company, CTT PHARMACEUTICAL HOLDINGS, INC. is not required to provide detailed risk factors, limiting investor insight into potential risks.
Business trends: Limited public information restricts visibility into business trends; financials indicate ongoing net losses and liquidity constraints.
Execution milestones: No disclosed recent milestones or strategic initiatives; smaller reporting company status limits detailed disclosures.
Key risks: Liquidity challenges, continued unprofitability, and lack of detailed risk disclosures increase operational and financial risk.
Moderate visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- CTT PHARMACEUTICAL HOLDINGS, INC. is a publicly reporting company with ticker CTTH.
- The latest SEC filing is a 10-Q filed on 2026-09-17 covering the period ending 2026-06-30 [S1].
- As of 2026-06-30, the company reported cash and cash equivalents of $32,121 USD and current liabilities of $41,391 USD, with current assets reported as $31 USD, resulting in a cash ratio of 0.78 [S1].
- The company reported a net loss of $99,908 USD for the period ending 2026-06-30 [S1].
- Diluted earnings per share for the period ending 2026-06-30 was reported as $0.00 USD [S1].
- The company is classified as a smaller reporting company and is not required to provide detailed risk factors in its SEC filings [S1].
Generated 2026-09-17
- S1 | 2026-09-17 | 10-Q
- N1 | 2026-09-17 | www.nasdaq.com | Stellantis' $25 Billion Gamble: Can a Fresh and Balanced Strategy Spark a Turnaround in Its Profit Engine? | https://www.nasdaq.com/articles/stellantis-25-billion-gamble-can-fresh-and-balanced-strategy-spark-turnaround-its-profit
- N2 | 2026-09-17 | www.nasdaq.com | Virtus Newfleet Short Duration Core Plus Bond (SDCP) Enters Oversold Territory | https://www.nasdaq.com/articles/virtus-newfleet-short-duration-core-plus-bond-sdcp-enters-oversold-territory
- N3 | 2026-09-17 | www.nasdaq.com | Cotton Faces Thursday Weakness, Following Slow Export Business | https://www.nasdaq.com/articles/cotton-faces-thursday-weakness-following-slow-export-business
- N4 | 2026-09-17 | www.nasdaq.com | Restaurant Brands International (QSR) Shares Cross Below 200 DMA | https://www.nasdaq.com/articles/restaurant-brands-international-qsr-shares-cross-below-200-dma
- N5 | 2026-09-17 | www.nasdaq.com | BKGI Shares Cross Above 200 DMA | https://www.nasdaq.com/articles/bkgi-shares-cross-above-200-dma
- N6 | 2026-09-17 | www.nasdaq.com | Here's What a $500 Investment in SpaceX Stock Could Be Worth by 2030 | https://www.nasdaq.com/articles/heres-what-500-investment-spacex-stock-could-be-worth-2030
- N7 | 2026-09-17 | www.nasdaq.com | Shares of BOEG Now Oversold | https://www.nasdaq.com/articles/shares-boeg-now-oversold
- N8 | 2026-09-17 | www.nasdaq.com | NUVB Makes Bullish Cross Above Critical Moving Average | https://www.nasdaq.com/articles/nuvb-makes-bullish-cross-above-critical-moving-average
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.
Generated by Valye SEC Pipeline Engine